Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip S Pang

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis CPhillip S Pang, Ahmad Kamal, Jeffrey S Glenn
Plos One|August 12, 2009
The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapyPhillip S Pang, Paul J Planet, Jeffrey S Glenn
Nucleic Acids Research|October 4, 2011
Simplified RNA secondary structure mapping by automation of SHAPE data analysisPhillip S Pang, Menashe Elazar, Edward A Pham, et al.
Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution|December 15, 2004
Prediction of functional tertiary interactions and intermolecular interfaces from primary sequence dataPhillip S Pang, Eckhard Jankowsky, Leven M Wadley, et al.
The EMBO Journal|February 28, 2002
The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwindingPhillip S Pang, Eckhard Jankowsky, Paul J Planet, et al.
Journal of Virology|November 11, 2011
Structural map of a microRNA-122: hepatitis C virus complexPhillip S Pang, Edward A Pham, Menashe Elazar, et al.
Antiviral Therapy|January 28, 2014
Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938Jeremie Guedj, Phillip S Pang, Jill Denning, et al.
Gastroenterology|August 12, 2015
Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infectionEdward J Gane, Robert H Hyland, Di An, et al.
The Lancet. Infectious Diseases|January 25, 2016
Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 studyArmand Abergel, Tarik Asselah, Sophie Metivier, et al.
Hepatology (Baltimore, Md.)|June 29, 2016
Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infectionArmand Abergel, Sophie Metivier, Didier Samuel, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis CPhillip S Pang, Ahmad Kamal, Jeffrey S Glenn
Plos One|August 12, 2009
The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapyPhillip S Pang, Paul J Planet, Jeffrey S Glenn
Nucleic Acids Research|October 4, 2011
Simplified RNA secondary structure mapping by automation of SHAPE data analysisPhillip S Pang, Menashe Elazar, Edward A Pham, et al.
Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution|December 15, 2004
Prediction of functional tertiary interactions and intermolecular interfaces from primary sequence dataPhillip S Pang, Eckhard Jankowsky, Leven M Wadley, et al.
The EMBO Journal|February 28, 2002
The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwindingPhillip S Pang, Eckhard Jankowsky, Paul J Planet, et al.
Journal of Virology|November 11, 2011
Structural map of a microRNA-122: hepatitis C virus complexPhillip S Pang, Edward A Pham, Menashe Elazar, et al.
Antiviral Therapy|January 28, 2014
Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938Jeremie Guedj, Phillip S Pang, Jill Denning, et al.
Gastroenterology|August 12, 2015
Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infectionEdward J Gane, Robert H Hyland, Di An, et al.
The Lancet. Infectious Diseases|January 25, 2016
Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 studyArmand Abergel, Tarik Asselah, Sophie Metivier, et al.
Hepatology (Baltimore, Md.)|June 29, 2016
Ledipasvir plus sofosbuvir for 12 weeks in patients with hepatitis C genotype 4 infectionArmand Abergel, Sophie Metivier, Didier Samuel, et al.
Pageof 5